-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $142

Benzinga·04/17/2025 17:05:28
Listen to the news
Raymond James analyst Jayson Bedford maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $132 to $142.